Mexichem's Zephex HFA medical propellant manufacturing facility in Cheshire UK has celebrated its 20th anniversary, the company announced. The Cheshire cGMP facility, which opened in 1995, is audited by both the FDA and MHRA. According to Mexichem, 80% of metered dose inhalers worldwide currently use propellants, and over the past 20 years, Zephex propellants have … [Read more...] about Zephex propellant production facility celebrates 20th anniversary
Products and Services
Hovione acquires new formulation facility in Portugal
Hovione has acquired a formulation facility located next to its existing Loures, Portugal facility for process chemistry and particle engineering, the company said. The new facility will be able to produce clinical trial supplies and commercial batches for both oral and inhalation drug products, including highly potent APIs. Hovione VP of R&D Filipe Gaspar … [Read more...] about Hovione acquires new formulation facility in Portugal
3M DDS partners with Impel NeuroPharma on intranasal delivery technology for CNS drugs
3M Drug Delivery Systems and Impel NeuroPharma have announced that the two companies will collaborate on development and commercialization of Impel’s Precision Olfactory Delivery (POD) platform for intranasal delivery of drugs to the central nervous system. No financial terms were disclosed. Impel CEO Michael Hite commented, “We are pleased to have 3M join our … [Read more...] about 3M DDS partners with Impel NeuroPharma on intranasal delivery technology for CNS drugs
Hovione to more than double size, capacity of New Jersey facility
Hovione, which offers a wide range of inhalation drug development and manufacturing services, has announced that it will add 30,600 sq ft and a new commercial spray dryer to its East Windsor, NJ facility. The expansion will more than double the plant's size and capacity, and the company said that it expects to hire approximately 60 new employees to support the … [Read more...] about Hovione to more than double size, capacity of New Jersey facility
Nemera announces availability of Advancia nasal spray pumps
Nemera has announced that after investing over 10 million euros, it now has the capacity to manufacture up to 45 million units of the Advancia user-independent nasal spray pump per year. The company, which was previously known as Rexam Healthcare Devices, says that one European country has approved the Advancia drug product packaging. Advancia is compatible with … [Read more...] about Nemera announces availability of Advancia nasal spray pumps
RMIT University to display surface acoustic wave nebulizer
RMIT University, located in Melbourn, Australia, has announced that it will display the Respite surface acoustic wave nebulizer at TechInnovation 2015. According to RMIT, the device can deliver drug at rates of 3 ml/min, with no meshes or nozzles that could clog. The Respite nebulizer has the ability to deliver DNA, proteins, and peptides, and RMIT researchers … [Read more...] about RMIT University to display surface acoustic wave nebulizer
KAER Biotherapeutics gets SBIR grant for aerosol delivery of surfactant
KAER Biotherapeutics has received a $291,000 Phase 1 Small Business Innovation Research (SBIR) grant from the National Heart Lung and Blood Institute of the National Institutes of Health for “Aerosol delivery of Surfactant for ARDS,” the company said. The grant will fund a study of surfactant aerosolization and delivery for the treatment of acute respiratory distress … [Read more...] about KAER Biotherapeutics gets SBIR grant for aerosol delivery of surfactant
Study examines DPI device/formulation interactions
A study by researchers from King's College London, the University of Parma, and inhalation testing specialist Intertek evaluating the interdependence of DPI formulation and device factors has been published in the International Journal of Pharmaceutics. The article, titled "Formulating powder–device combinations for salmeterol xinafoate dry powder inhalers," appeared … [Read more...] about Study examines DPI device/formulation interactions
Adherium (formerly Nexus6) partners with AstraZeneca
Smartinhaler maker Adherium (formerly Nexus6) has announced a new deal to provide AstraZeneca with devices and sensors for use in asthma and COPD patient support programs. AstraZeneca has already used the Adherium technology in clinical trials. Studies have verified that Smartinhaler use significantly increases adherence to asthma medications both in children and … [Read more...] about Adherium (formerly Nexus6) partners with AstraZeneca
Gerresheimer reports increase in revenues in second quarter
Device manufacturer Gerresheimer reported a 6.3% increase in revenues and a 7.4% increase in net income in the second quarter of 2015, crediting "very strong growth" in medical plastic products such as inhalers. According to the company, it is continuing to expand its production capacity for inhalers and other plastic products in the Czech Republic and in the US. … [Read more...] about Gerresheimer reports increase in revenues in second quarter